(TRST) TrustCo Bank NY - Overview
Stock: Deposits, Loans, Mortgages, Investment, Trust
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.14% |
| Yield on Cost 5y | 5.55% |
| Yield CAGR 5y | 7.70% |
| Payout Consistency | 94.8% |
| Payout Ratio | 48.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 28.8% |
| Relative Tail Risk | -14.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.36 |
| Alpha | 35.12 |
| Character TTM | |
|---|---|
| Beta | 0.678 |
| Beta Downside | 0.682 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.96% |
| CAGR/Max DD | 0.41 |
Description: TRST TrustCo Bank NY December 26, 2025
TrustCo Bank Corp NY (NASDAQ: TRST) is the holding company for Trustco Bank, a community-focused financial institution that offers personal and business banking, deposit taking, loan origination, and investment services.
Beyond traditional banking, the firm operates a real-estate investment trust (REIT) that purchases and manages residential mortgage assets and mortgage-backed securities, while also providing estate-execution, trust, wealth-management, and custodial services for employee benefit and pension plans.
The bank’s branch network spans 17 counties in New York, 18 counties in Florida, plus locations in Vermont, Massachusetts, and New Jersey, complemented by a statewide ATM footprint.
As of the latest quarter (Q4 2023), TrustCo reported a net interest margin of approximately 3.1%, a loan portfolio of $5.2 billion, and total deposits of $7.0 billion, yielding a return on equity near 8.5%-metrics that sit modestly above the regional-bank average but remain sensitive to interest-rate shifts.
The regional-bank sector is currently driven by the Federal Reserve’s policy cycle: higher policy rates boost net interest income but also raise funding costs and credit-risk exposure, especially in markets with elevated housing price volatility such as Florida.
For a deeper, data-rich analysis of TRST’s valuation dynamics, you may find ValueRay’s platform useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 61.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.24 > 1.0 |
| NWC/Revenue: 86.56% < 20% (prev -1950 %; Δ 2037 % < -1%) |
| CFO/TA 0.01 > 3% & CFO 55.5m > Net Income 61.1m |
| Net Debt (69.5m) to EBITDA (89.8m): 0.77 < 3 |
| Current Ratio: 3.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.3m) vs 12m ago -3.72% < -2% |
| Gross Margin: 67.07% > 18% (prev 0.65%; Δ 6643 % > 0.5%) |
| Asset Turnover: 4.39% > 50% (prev 4.22%; Δ 0.17% > 0%) |
| Interest Coverage Ratio: 0.66 > 6 (EBITDA TTM 89.8m / Interest Expense TTM 90.4m) |
Altman Z'' 0.64
| A: 0.04 (Total Current Assets 361.0m - Total Current Liabilities 120.1m) / Total Assets 6.44b |
| B: 0.07 (Retained Earnings 480.0m / Total Assets 6.44b) |
| C: 0.01 (EBIT TTM 59.8m / Avg Total Assets 6.34b) |
| D: 0.09 (Book Value of Equity 510.1m / Total Liabilities 5.75b) |
| Altman-Z'' Score: 0.64 = B |
What is the price of TRST shares?
Over the past week, the price has changed by +6.15%, over one month by +11.20%, over three months by +19.84% and over the past year by +45.00%.
Is TRST a buy, sell or hold?
What are the forecasts/targets for the TRST price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26 | -43.6% |
| Analysts Target Price | 26 | -43.6% |
| ValueRay Target Price | 53.4 | 15.9% |
TRST Fundamental Data Overview February 03, 2026
P/S = 4.2916
P/B = 1.1331
P/EG = 3.73
Revenue TTM = 278.3m USD
EBIT TTM = 59.8m USD
EBITDA TTM = 89.8m USD
Long Term Debt = 72.8m USD (estimated: total debt 192.8m - short term 120.1m)
Short Term Debt = 120.1m USD (from shortTermDebt, last quarter)
Debt = 192.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 69.5m USD (from netDebt column, last quarter)
Enterprise Value = 565.3m USD (733.5m + Debt 192.8m - CCE 361.0m)
Interest Coverage Ratio = 0.66 (Ebit TTM 59.8m / Interest Expense TTM 90.4m)
EV/FCF = 12.95x (Enterprise Value 565.3m / FCF TTM 43.6m)
FCF Yield = 7.72% (FCF TTM 43.6m / Enterprise Value 565.3m)
FCF Margin = 15.68% (FCF TTM 43.6m / Revenue TTM 278.3m)
Net Margin = 21.97% (Net Income TTM 61.1m / Revenue TTM 278.3m)
Gross Margin = 67.07% ((Revenue TTM 278.3m - Cost of Revenue TTM 91.6m) / Revenue TTM)
Gross Margin QoQ = 68.30% (prev 67.25%)
Tobins Q-Ratio = 0.09 (Enterprise Value 565.3m / Total Assets 6.44b)
Interest Expense / Debt = 11.59% (Interest Expense 22.4m / Debt 192.8m)
Taxrate = 26.07% (5.49m / 21.1m)
NOPAT = 44.2m (EBIT 59.8m * (1 - 26.07%))
Current Ratio = 3.01 (Total Current Assets 361.0m / Total Current Liabilities 120.1m)
Debt / Equity = 0.28 (Debt 192.8m / totalStockholderEquity, last quarter 686.6m)
Debt / EBITDA = 0.77 (Net Debt 69.5m / EBITDA 89.8m)
Debt / FCF = 1.59 (Net Debt 69.5m / FCF TTM 43.6m)
Total Stockholder Equity = 689.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.96% (Net Income 61.1m / Total Assets 6.44b)
RoE = 8.86% (Net Income TTM 61.1m / Total Stockholder Equity 689.8m)
RoCE = 7.84% (EBIT 59.8m / Capital Employed (Equity 689.8m + L.T.Debt 72.8m))
RoIC = 5.68% (NOPAT 44.2m / Invested Capital 778.3m)
WACC = 8.44% (E(733.5m)/V(926.3m) * Re(8.41%) + D(192.8m)/V(926.3m) * Rd(11.59%) * (1-Tc(0.26)))
Discount Rate = 8.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.85%
[DCF Debug] Terminal Value 75.25% ; FCFF base≈49.1m ; Y1≈45.5m ; Y5≈41.4m
Fair Price DCF = 33.22 (EV 681.6m - Net Debt 69.5m = Equity 612.1m / Shares 18.4m; r=8.44% [WACC]; 5y FCF grow -9.21% → 2.90% )
EPS Correlation: -51.17 | EPS CAGR: 0.46% | SUE: 1.44 | # QB: 3
Revenue Correlation: 93.51 | Revenue CAGR: 11.76% | SUE: 1.06 | # QB: 10